Bibangco, Poren H.

HRN: 27-96-09  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/15/2025
CEFUROXIME 750MG (VIAL)
10/15/2025
10/22/2025
IV
750 MG
Q8HRS
ACUTE CHOLECYSTITIS
01/07/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
01/07/2026
01/14/2026
IV
4.5g
Q8h
Intraabdominal Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: